<?xml version="1.0" encoding="UTF-8"?>
<p>Limited studies and research regarding preparedness plans for the care of cancer patients during an infectious pandemic exist 
 <xref rid="onco13306-bib-0009" ref-type="ref">9</xref>, 
 <xref rid="onco13306-bib-0010" ref-type="ref">10</xref>. In this review, we aim specifically to address challenges associated with cancer care during the COVID‐19 pandemic. Recent literature 
 <xref rid="onco13306-bib-0001" ref-type="ref">1</xref>, 
 <xref rid="onco13306-bib-0009" ref-type="ref">9</xref>, 
 <xref rid="onco13306-bib-0010" ref-type="ref">10</xref>, 
 <xref rid="onco13306-bib-0011" ref-type="ref">11</xref>, 
 <xref rid="onco13306-bib-0012" ref-type="ref">12</xref>, 
 <xref rid="onco13306-bib-0013" ref-type="ref">13</xref>, 
 <xref rid="onco13306-bib-0014" ref-type="ref">14</xref> has already extensively addressed the virology, diagnosis, and treatment of COVID‐19 and is beyond the scope of this paper 
 <xref rid="onco13306-bib-0002" ref-type="ref">2</xref>, 
 <xref rid="onco13306-bib-0011" ref-type="ref">11</xref>, 
 <xref rid="onco13306-bib-0012" ref-type="ref">12</xref>, 
 <xref rid="onco13306-bib-0013" ref-type="ref">13</xref>, 
 <xref rid="onco13306-bib-0014" ref-type="ref">14</xref>, 
 <xref rid="onco13306-bib-0015" ref-type="ref">15</xref>, 
 <xref rid="onco13306-bib-0016" ref-type="ref">16</xref>.
</p>
